Senzime AB

6YC

Company Profile

  • Business description

    Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.

  • Contact

    Verkstadsgatan 8, hus 1
    Uppsala753 23
    SWE

    T: +46 18515640

    https://www.senzime.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    58

Stocks News & Analysis

stocks

Beaten down real estate share receives legal blow

Real estate share remains cheap despite losing airport legal battle.
stocks

OpenAI joins the mega-AI lab IPO race, but timing is uncertain

The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.
stocks

What happens if Tesla and SpaceX merge?

We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,006.1029.100.32%
CAC 408,350.87150.081.83%
DAX 4024,635.30425.591.76%
Dow JONES (US)51,202.26353.510.70%
FTSE 10010,471.72167.841.63%
HKSE24,718.10468.811.93%
NASDAQ25,888.8479.180.31%
Nikkei 22566,020.041,802.772.81%
NZX 50 Index13,393.87191.711.45%
S&P 5007,431.4637.160.50%
S&P/ASX 2008,804.0030.500.35%
SSE Composite Index4,031.5144.501.12%

Market Movers